Tag: Therapeutics
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulcrum Therapeutics, Inc. Investors w… –...
NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Invest… –...
NEW YORK, May 26, 2023 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics...
Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Th…...
DUBLIN, May 22, 2023 /PRNewswire/ -- The "Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investo… – Press...
NEW YORK, May 20, 2023 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investor… –...
NEW YORK, May 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common…...
EMERYVILLE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. FDMT, a clinical-stage biotherapeutics company harnessing the power of...
XNK Therapeutics Enters into Research Agreement with Global Pharma Company ...
HUDDINGE, Sweden, May 4, 2023 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced that the company's autologous natural killer (NK) cell therapy candidate XNK04...
Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference –...
PALO ALTO, Calif. and MIAMI, Fla., May 03, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. KTTA ("Pasithea" or the "Company"), a...
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting ...
SHANGHAI, May 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet...
Pediatric Osteosarcoma Therapeutics Market Exhibits a Revenue CAGR of 4.1% Durin…...
Newark, New Castle, USA, April 25, 2023 (GLOBE NEWSWIRE) -- As per the report by Growth Plus Reports, the global pediatric...